Antitrust concerns and the FDA approval process : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017.
Author/creator | United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law |
Format | Electronic and Book |
Publication Info | Washington : U.S. Government Publishing Office, 2018. |
Description | 1 online resource (iv, 51 pages) |
Supplemental Content | https://purl.fdlp.gov/GPO/gpo93483 |
Subject(s) |
Click here for more information about this title
Variant title | Antitrust concerns and the Food and Drug Administration approval process |
General note | "Serial no. 115-27." |
General note | CRDP Program record. |
Source of description | Online resource; title from PDF title screens (govinfo web site, viewed on June 27, 2018). |
Issued in other form | Print version: United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law. Antitrust concerns and the FDA approval process |
Issued in other form | Microfiche version: United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law. Antitrust concerns and the FDA approval process |
Genre/form | Legislative hearings. |
Genre/form | Rules. |
Genre/form | Legislative hearings. |
Technical rpt number | Serial no. 115-27 (United States. Congress. House. Committee on the Judiciary) |
GPO item number | 1020-C (online) |
Govt. docs number | Y 4.J 89/1:115-27 |
Available Items
Library | Location | Call Number | Status | Item Actions | |
Joyner | Electronic Resources | Access Content Online | ✔ Available |